Aurinia Pharmaceuticals Inc (AUP.TO)
AUP.TO on Toronto Stock Exchange
7.53CAD
16 Jul 2018
7.53CAD
16 Jul 2018
Change (% chg)
$-0.30 (-3.83%)
$-0.30 (-3.83%)
Prev Close
$7.83
$7.83
Open
$7.85
$7.85
Day's High
$8.01
$8.01
Day's Low
$7.50
$7.50
Volume
46,780
46,780
Avg. Vol
35,437
35,437
52-wk High
$9.75
$9.75
52-wk Low
$5.68
$5.68
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 0.03 | -0.184 |
| FY 2017 | Dec '17 | 0.03 | -0.040 |
| Sep '17 | 0.03 | -0.157 | |
| Jun '17 | 0.33 | -0.029 | |
| Mar '17 | 0.03 | -0.916 | |
| FY 2016 | Dec '16 | 0.03 | -0.207 |
| Sep '16 | 0.03 | -0.206 | |
| Jun '16 | 0.05 | -0.101 | |
| Mar '16 | 0.06 | -0.132 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-18 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Quarter Ending Dec-18 | 2 | 0.07 | 0.10 | 0.03 | -- |
| Year Ending Dec-18 | 3 | 0.18 | 0.30 | 0.12 | 0.17 |
| Year Ending Dec-19 | 3 | 0.15 | 0.20 | 0.12 | 0.14 |
| Earnings (per share) | |||||
| Quarter Ending Sep-18 | 2 | -0.17 | -0.14 | -0.19 | -- |
| Quarter Ending Dec-18 | 2 | -0.16 | -0.11 | -0.20 | -- |
| Year Ending Dec-18 | 3 | -0.63 | -0.57 | -0.74 | -0.70 |
| Year Ending Dec-19 | 3 | -0.63 | -0.44 | -0.88 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 85.48 | 32.76 | |
| P/E High - Last 5 Yrs. | -- | 298.85 | 45.44 | |
| P/E Low - Last 5 Yrs. | -- | 91.59 | 24.26 | |
| Beta | 2.13 | 0.93 | 0.89 | |
| Price to Sales (TTM) | 1,306.17 | 112.69 | 5.73 | |
| Price to Book (MRQ) | 3.08 | 14.09 | 5.45 | |
| Price to Tangible Book (MRQ) | 3.36 | 14.67 | 7.05 | |
| Price to Cash Flow (TTM) | -- | 72.72 | 23.29 | |
| % Owned Institutions | -- | 14.42 | 2.21 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.35 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.27 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 1.70 | 5.22 | |
| Payout Ratio(TTM) | -- | 16.38 | 43.78 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 498.18 | 408.74 | 8.01 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 86.28 | 80.05 | 5.64 | |
| Sales - 5 Yr. Growth Rate | -28.98 | 32.09 | 10.18 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 71.27 | 29.06 | 20.60 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -161.99 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 39.56 | 10.66 | |
| Capital Spending - 5 Yr. Growth Rate | -53.80 | 40.05 | 15.33 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.92 | 2.22 |
| Current Ratio (MRQ) | 53.07 | 5.50 | 3.03 |
| LT Debt to Equity (MRQ) | 0.00 | 25.57 | 12.39 |
| Total Debt to Equity (MRQ) | 0.00 | 27.28 | 16.72 |
| Interest Coverage (TTM) | -- | -101.33 | 32.64 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 99.29 | 39.25 | 54.37 | |
| Gross Margin - 5 Yr. Avg. | 98.72 | 50.67 | 52.17 | |
| EBITD Margin (TTM) | -7,859.62 | -- | -- | |
| EBITD - 5 Yr. Avg | -847.60 | -588.18 | 10.81 | |
| Operating Margin (TTM) | -8,206.41 | -734.89 | 4.57 | |
| Operating Margin - 5 Yr. Avg. | -984.31 | -609.81 | 6.23 | |
| Pre-Tax Margin (TTM) | -16,648.93 | -708.96 | 5.43 | |
| Pre-Tax Margin - 5 Yr. Avg. | -996.77 | -613.30 | 6.67 | |
| Net Profit Margin (TTM) | -16,648.93 | -710.36 | 1.73 | |
| Net Profit Margin - 5 Yr. Avg. | -946.52 | -616.33 | 2.94 | |
| Effective Tax Rate (TTM) | -- | 23.27 | 23.11 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.59 | 23.98 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 26,384 | 23,066,163 | 860,414,722 | |
| Net Income/Employee (TTM) | -4,392,666 | 3,124,085 | 101,211,891 | |
| Receivable Turnover (TTM) | 2.52 | 20.78 | 5.87 | |
| Inventory Turnover (TTM) | -- | 2.48 | 3.41 | |
| Asset Turnover (TTM) | 0.00 | 0.41 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -58.90 | 0.33 | 11.14 | |
| Return on Assets - 5 Yr. Avg. | -49.46 | 3.75 | 12.40 | |
| Return on Investment (TTM) | -60.83 | 2.29 | 14.61 | |
| Return on Investment - 5 Yr. Avg. | -57.68 | 2.93 | 16.14 | |
| Return on Equity (TTM) | -70.80 | 3.86 | 16.34 | |
| Return on Equity - 5 Yr. Avg. | -85.46 | 4.40 | 17.40 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -26.38 | -43.69 | -28.98 |
| EPS (TTM) % | -14.09 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Aurinia Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 1.10 | -3.68 | 96 | 53 |
| 13 Week | 0.73 | -3.76 | 99 | 66 |
| 26 Week | -12.39 | -12.73 | 77 | 79 |
| 52 Week | 22.88 | 14.03 | 99 | 52 |
| YTD | 192.23 | 184.04 | 99 | 61 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 29.22% |
| # of Holders: | 81 |
| Total Shares Held: | 24,684,681 |
| 3 Mo. Net Change: | 422 |
| # New Positions: | 0 |
| # Closed Positions: | 1 |
| # Increased Positions: | 2 |
| # Reduced Positions: | 3 |
| # Net Buyers: | -1 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.